Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Acquisitions (2016 - 2022)

Icu Medical (ICUI) has disclosed Acquisitions for 8 consecutive years, with $1.8 billion as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Acquisitions changed N/A year-over-year to $1.8 billion, compared with a TTM value of $1.8 billion through Dec 2022, up 12660.61%, and an annual FY2022 reading of $1.8 billion, up 12660.61% over the prior year.
  • Acquisitions was $1.8 billion for Q1 2022 at Icu Medical, up from $14.5 million in the prior quarter.
  • Across five years, Acquisitions topped out at $1.8 billion in Q1 2022 and bottomed at $1.3 million in Q2 2018.
  • Average Acquisitions over 4 years is $482.9 million, with a median of $43.0 million recorded in 2019.